Showing results (891-900 of 957) with videos related to

Sort By:
Pageof 96
BMC Nursing|May 28, 2026
Importance ranking and predictive model construction of WMSDs risk factors among shift-working nurses based on multiple machine-learning algorithmsLi-Chong Lai, Hai-Chen Wu, Xiao-Ying Cao, et al.
Frontiers in Immunology|October 15, 2021
Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells <i>via</i> IL-33/ST2 SignalingFan Deng, Jing-Juan Hu, Xiao Yang, et al.
Neuropathology and Applied Neurobiology|February 22, 2022
Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adultsZhi-Feng Shi, Kay Ka-Wai Li, Queenie Jun-Qi Huang, et al.
Journal of Lipid Research|July 6, 2013
Effects of small interfering RNA-mediated hepatic glucagon receptor inhibition on lipid metabolism in db/db miceSeongah Han, Taro E Akiyama, Stephen F Previs, et al.
Gut Microbes|April 13, 2025
Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrateJing-Juan Hu, Fan Deng, Qi-Shun Sun, et al.
Military Medical Research|October 28, 2025
Trace element-dictated exosome modules and self-adaptive dual-network hydrogel orchestrate diabetic foot regeneration through complement-mitochondria-autophagy circuitryShuang-Qing Wang, Ming-Ji Jin, Ze-Ke Guo, et al.
Theranostics|March 4, 2017
Phenytoin silver: a new nanocompound for promoting dermal wound healing via comprehensive pharmacological actionXiao-Yu Ai, Hui-Juan Liu, Cheng Lu, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Design of potent and selective GPR119 agonists for type II diabetesJason W Szewczyk, John Acton, Alan D Adams, et al.
Cancer Research|May 3, 2011
Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinomaNing Ren, Jin-Cai Wu, Qiong-Zhu Dong, et al.
Nature Communications|September 6, 2023
Exosomal circEZH2_005, an intestinal injury biomarker, alleviates intestinal ischemia/reperfusion injury by mediating Gprc5a signalingWenjuan Zhang, Bowei Zhou, Xiao Yang, et al.
Pageof 96